Growth Metrics

Cumberland Pharmaceuticals (CPIX) Gains from Investment Securities (2019 - 2026)

Cumberland Pharmaceuticals' Gains from Investment Securities history spans 8 years, with the latest figure at $345082.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 63.72% to $345082.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $438311.0, a 2822.07% increase, with the full-year FY2025 number at $438311.0, up 2822.07% from a year prior.
  • Gains from Investment Securities hit $345082.0 in Q4 2025 for Cumberland Pharmaceuticals, up from $9651.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for CPIX hit a ceiling of $1.1 million in Q4 2023 and a floor of -$1.0 million in Q4 2022.
  • Historically, Gains from Investment Securities has averaged -$74798.8 across 5 years, with a median of -$210430.0 in 2023.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 263.9% in 2022 and later surged 208.7% in 2023.
  • Tracing CPIX's Gains from Investment Securities over 5 years: stood at $632319.0 in 2021, then tumbled by 263.9% to -$1.0 million in 2022, then surged by 208.7% to $1.1 million in 2023, then dropped by 15.58% to $951072.0 in 2024, then tumbled by 63.72% to $345082.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for CPIX at $345082.0 in Q4 2025, $9651.0 in Q3 2025, and $38602.0 in Q2 2025.